Abstract
We have already established the strategy of synchronous activation by hybridization, in which the highly reactive cross-linking agent, 2-amino-6-vinylpurine nucleoside analog, can be generated from its stable precursors, the phenylsulfide derivatives, by a hybridization-promoted activation process with selectivity to cytosine. In this study, this in situ activation system was applied to the method for the drug releasing system triggered by hybridization with the target sequence.
Original language | English |
---|---|
Pages (from-to) | 799-803 |
Number of pages | 5 |
Journal | Nucleosides, Nucleotides and Nucleic Acids |
Volume | 26 |
Issue number | 6-7 |
DOIs | |
Publication status | Published - 2007 Jun |
Keywords
- 2-amino-6-vinylpurine
- Cross-link
- Drug releasing system
- FRET
- Oligonucleotides
- Synchronous activation
ASJC Scopus subject areas
- Biochemistry
- Molecular Medicine
- Genetics